Virtual Care With Nonusual Physician Tied to More Emergency Visits
By Lori Solomon HealthDay Reporter
WEDNESDAY, Dec. 27, 2023 -- Virtual care with an outside physician is associated with more emergency department visits, compared with virtual visits with a regular care physician, according to a study published online Dec. 27 in JAMA Network Open.
Lauren Lapointe-Shaw, M.D., Ph.D., from University Health Network in Toronto, and colleagues investigated whether there was a difference in subsequent emergency department use between patients who had a virtual visit with their own family physician versus those who had virtual visits with an outside physician. The analysis included 5.2 million individuals with a family physician and virtual visit (April 1, 2021, to March 31, 2022).
The researchers found that when propensity score matching those with a personal versus outside physician, those who saw an outside physician were 66 percent more likely to visit an emergency department within seven days of the virtual visit versus those who virtually saw their own physician (3.3 versus 2.0 percent; risk difference, 1.3 percent; relative risk, 1.66). The risk was even greater for patients with definite direct-to-consumer telemedicine visits versus patients with own physician visits (risk difference, 4.1 percent; relative risk, 2.99).
"These findings suggest that primary care virtual visits may be best used within an existing clinical relationship," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted December 2023
Read this next
AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours
WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
Patient–Primary Care Provider Language Concordance Tied to Better Outcomes
TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.